Naming and labelling of biologicals – a survey of US physicians’ perspectives

Introduction: The US Food and Drug Association (FDA) released its requirements for the non-proprietary naming of biological products in January 2017. Before the FDA's release, the Alliance for Safe Biologic Medicines (ASBM) asked physicians for their views on the labelling and naming of biosimi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	GaBI Journal 2017-03, Vol.6 (1), p.7-12
Hauptverfasser:	Gewanter, Harry L, Reilly, Michael S
Format:	Artikel
Sprache:	eng
Schlagworte:	Hostages Surveys
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!